EYGELSHOVEN, Netherlands – Combining efforts, the 405th Army Field Support Brigade's Battalion Benelux, Materieellogistiek Commando and the 59th Chemical Company (Hazardous Response) conducted an Army Prepositioned Stocks-2 issue at the Eygelshoven APS-2 worksite in the Netherlands at the start of DEFENDER 25.
More than 200 APS-2 major end items were issued May 12-13 to the U.S.-based Soldiers from Fort Drum, N.Y., deployed to Europe for DEFENDER 25. Items included several M1135 Stryker NBC reconnaissance vehicles and Humvees, 5-ton trucks, almost 20 light medium tactical vehicles, a wrecker, and more. Dozens of radios and receivers/transmitters were also issued as well as NBC decontamination equipment, containers, generators, trailers, tools and test kits, and more. The APS-2 tactical vehicles and equipment items from Eygelshoven will be used by the Soldiers from 59th Chem. Co. (HR), 48th Chemical Brigade, during DEFENDER 25 at various locations in northeastern Greece.
DEFENDER 25 is the largest series of U.S. Army exercises in Europe involving about 23,000 troops from the U.S., Allied and partner nations. DEFENDER 25 runs from May 11 to June 24, 2025, in 15 countries across Europe. The large-scale exercises and deployment rehearsals conducted during DEFENDER 25 converge U.S. and NATO systems, capabilities and tactics supporting U.S. strategic initiatives and NATO regional plans to dominate multi-domain environments in a crisis. To view more DEFENDER 25 media products, go to www.dvidshub.net/feature/defendereurope. To learn more about DEFENDER 25, visit www.europeafrica.army.mil/Defender.
Date Taken: | 05.12.2025 |
Date Posted: | 05.14.2025 04:15 |
Photo ID: | 9035079 |
VIRIN: | 250513-A-SM279-7394 |
Resolution: | 3112x1636 |
Size: | 1.21 MB |
Location: | EYGELSHOVEN, NL |
Web Views: | 17 |
Downloads: | 0 |
This work, 405th AFSB ‘I’M A DEFENDER’ Army Prepositioned Stocks-2 issue in the Netherlands, by Cameron Porter, identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.